The DOI matches its Crossref record; 423 of the 423 references it cites were found in a registry or an index.
Candidate biomarkers in psychiatric disorders: state of the field
Open accessAbstract
The field of psychiatry is hampered by a lack of robust, reliable and valid biomarkers that can aid in objectively diagnosing patients and providing individualized treatment recommendations. Here we review and critically evaluate the evidence for the most promising biomarkers in the psychiatric neuroscience literature for autism spectrum disorder, schizophrenia, anxiety disorders and post‐traumatic stress disorder, major depression and bipolar disorder, and substance use disorders. Candidate biomarkers reviewed include various neuroimaging, genetic, molecular and peripheral assays, for the purposes of determining susceptibility or presence of illness, and predicting treatment response or safety. This review highlights a critical gap in the biomarker validation process. An enormous societal investment over the past 50 years has identified numerous candidate biomarkers. However, to date, the overwhelming majority of these measures have not been proven sufficiently reliable, valid and useful to be adopted clinically. It is time to consider whether strategic investments might break this impasse, focusing on a limited number of promising candidates to advance through a process of definitive testing for a specific indication. Some promising candidates for definitive testing include the N170 signal, an event‐related brain potential measured using electroencephalography, for subgroup identification within autism spectrum disorder; striatal resting‐state functional magnetic resonance imaging (fMRI) measures, such as the striatal connectivity index (SCI) and the functional striatal abnormalities (FSA) index, for prediction of treatment response in schizophrenia; error‐related negativity (ERN), an electrophysiological index, for prediction of first onset of generalized anxiety disorder, and resting‐state and structural brain connectomic measures for prediction of treatment response in social anxiety disorder. Alternate forms of classification may be useful for conceptualizing and testing potential biomarkers. Collaborative efforts allowing the inclusion of biosystems beyond genetics and neuroimaging are needed, and online remote acquisition of selected measures in a naturalistic setting using mobile health tools may significantly advance the field. Setting specific benchmarks for well‐defined target application, along with development of appropriate funding and partnership mechanisms, would also be crucial. Finally, it should never be forgotten that, for a biomarker to be actionable, it will need to be clinically predictive at the individual level and viable in clinical settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–423 of 423
Schiele, M. A., Reif, A., Lin, J., Alpers, G. W., Andersson, E., Andersson, G., Arolt, V., Bergström, J., Carlbring, P., Eley, T. C., et al. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.01.004 · Cited by 18
Self-citationAvoidant coping in panic disorder: A yohimbine biological challenge study
Kaplan, J. S., Arnkoff, D. B., Glass, C. R., Tinsley, R., Geraci, M., Hernandez, E., Luckenbaugh, D., Drevets, W. C., & Carlson, P. J. (2012) · Anxiety, Stress, & Coping · doi:10.1080/10615806.2011.609587 · Cited by 17
Widmayer, S., Borgwardt, S., Lang, U. E., Stieglitz, R., & Huber, C. G. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00777 · Cited by 17
Personalized Clinical Approaches to Anxiety Disorders
Perna, G., Alciati, A., Sangiorgio, E., Caldirola, D., & Nemeroff, C. B. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-32-9705-0_25 · Cited by 15
Prevention in psychiatry: a role for epigenetics?
Domschke, K. (2021) · World Psychiatry · doi:10.1002/wps.20854 · Cited by 15
Self-citationLi, C., Liang, X., Cheng, S., Wen, Y. F., Pan, C., Zhang, H., Chen, Y., Zhang, Z., Zhang, Z., Yang, X., et al. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.01.009 · Cited by 15
Circadian Rhythms and Mood Disorders: A Guide for the Perplexed
Lewy, A. J. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14com09716 · Cited by 14
Blunted Frontostriatal Blood Oxygen Level–Dependent Signals Predict Stimulant and Marijuana Use
Blair, M. A., Stewart, J. L., May, A. C., Reske, M., Tapert, S. F., & Paulus, M. P. (2018) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2018.03.005 · Cited by 14
Self-citationKegeles, L. S., Ciarleglio, A., León-Ortíz, P., Reyes-Madrigal, F., Lieberman, J. A., Brucato, G., Girgis, R. R., & de la Fuente‐Sandoval, C. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.09.004 · Cited by 14
Towards a framework to develop neuroimaging biomarkers of relapse in schizophrenia
Rubio, J. M., Malhotra, A. K., & Kane, J. M. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.113099 · Cited by 13
Self-citationStriatal functional connectivity in psychosis relapse: A hypothesis generating study
Rubio, J. M., Lencz, T., Barber, A. D., Moyett, A., Ali, S., Bassaw, F., Ventura, G., Germano, N., Malhotra, A. K., & Kane, J. M. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.06.010 · Cited by 12
Self-citationAsselmann, E., Hertel, J., Schmidt, C., Homuth, G., Nauck, M., Beesdo-Baum, K., Grabe, H., & Pané-Farré, C. (2018) · Depression and Anxiety · doi:10.1002/da.22812 · Cited by 11
Scherf‐Clavel, M., Weber, H., Deckert, J., & Erhardt, A. (2021) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1991912 · Cited by 11
Intermediate stable states in substance use
Epskamp, S., van der Maas, H. L. J., Peterson, R. E., van Loo, H. M., Aggen, S. H., & Kendler, K. S. (2022) · Addictive Behaviors · doi:10.1016/j.addbeh.2022.107252 · Cited by 11
Parikh, A., Moeller, S. J., & Garland, E. L. (2022) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2021.2007258 · Cited by 11
Self-citationInteraction of Cannabis Use Disorder and Striatal Connectivity in Antipsychotic Treatment Response
Thies, M. B., DeRosse, P., Sarpal, D. K., Árgyelán, M., Fales, C. L., Gallego, J. A., Robinson, D. G., Lencz, T., Homan, P., & Malhotra, A. K. (2020) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgaa014 · Cited by 10
Filippi, I., Galinowski, A., Lemaître, H., Massot, C., Zillé, P., Frère, P., Miranda, R., Trichard, C., Guldner, S., Vulser, H., et al. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.03.001 · Cited by 10
Neural activation to loss and reward among alcohol naive adolescents who later initiate alcohol use
Gonçalves, S. F., Turpyn, C. C., Niehaus, C. E., Mauro, K. L., Hinagpis, C. L., Thompson, J. C., & Chaplin, T. M. (2021) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2021.100978 · Cited by 10
Qi, W., Marx, J., Zingman, M., Li, Y., Petkova, E., Blessing, E., Ardekani, B. A., Kani, A. S., Cather, C., Freudenreich, O., et al. (2022) · Schizophrenia Bulletin · doi:10.1093/schbul/sbac043 · Cited by 10
Maron, E., Lan, C.-C., & Nutt, D. (2018) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2018_49 · Cited by 9
Robinaugh, D. J., Ward, M. J., Toner, E. R., Brown, M. L., Losiewicz, O. M., Bui, É., & Orr, S. P. (2019) · General Psychiatry · doi:10.1136/gpsych-2019-100140 · Cited by 9
Functional neuroimaging in mood disorders
Frangou, S. (2009) · Psychiatry · doi:10.1016/j.mppsy.2008.12.004 · Cited by 6
Biomarkers for Antidepressant Selection: iSPOT-D Study
Palmer, D. M. (2015) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-015-0046-1 · Cited by 3
Cited by
Marx, W., Penninx, B. W. J. H., Solmi, M., Furukawa, T. A., Firth, J., Carvalho, A. F., & Berk, M. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00454-1 · Cited by 768
Domschke, K., Seuling, P. D., Schiele, M. A., Bandelow, B., Batelaan, N. M., Bokma, W. A., Branchi, I., Broich, K., Burkauskas, J., Davies, S. J. C., et al. (2024) · World Psychiatry · doi:10.1002/wps.21177 · Cited by 46
Self-citationUnveiling the interoception impairment in various major depressive disorder stages
Zhou, H., Liu, J., Wu, Y., Huang, Z., Wang, W., Ma, Y., Zhu, H., Zhou, Z., Wang, J., & Jiang, C. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14923 · Cited by 13
Schiele, M. A., Crespo Salvador, O., Lipovsek, J., Schwarte, K., Schlosser, P., Zwanzger, P., Arolt, V., Baune, B. T., Köttgen, A., & Domschke, K. (2024) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyae045 · Cited by 13
Self-citationObsessive-compulsive disorder – A state-of-the-art review
Endres, D., Schiele, M. A., von Zedtwitz, K., Dressle, R. J., Maier, A., Hohagen, F., Baldermann, J. C., Coenen, V. A., Jelinek, L., Domschke, K., et al. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106320 · Cited by 11
Self-citation
Metadata
- Authors
- Abi‐Dargham, A., Moeller, S. J., Ali, F., DeLorenzo, C., Domschke, K., Horga, G., Jutla, A., Kotov, R., Paulus, M. P., Rubio, J. M., Sanacora, G., Veenstra‐VanderWeele, J., & Krystal, J. H.
- Venue
- World Psychiatry
- Publisher
- Wiley
- Published
- 2023-05-09
- Volume
- 22
- Issue
- 2
- Pages
- 236-262
- ISSN
- 1723-8617 (ISSN-L)
- 2051-5545
- OpenAlex
- W4376108699
- Cited by
- 372
- References
- 423
- FWCI
- 66.56
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.